As many as five pharma companies are planning to hit the Indian markets with their initial public offerings (IPOs) in August including two – Windlas Biotech and Krsnaa Diagnostics, that are set to open for subscription in the first week of the month on August 4.

The list also include the ₹4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the ₹1,500-crore issue by Vijaya Diagnostic Centre and Mumbai-based bulk drugs maker Supriya Lifesciences ( ₹1,200 crore). Investment bankers estimate these five companies to together raise over ₹8,300 crore through the public offerings this month, reported news agency PTI.

Leave a Reply

Your email address will not be published. Required fields are marked *

As many as five pharma companies are planning to hit the Indian markets with their initial public offerings (IPOs) in August including two – Windlas Biotech and Krsnaa Diagnostics, that are set to open for subscription in the first week of the month on August 4.

The list also include the ₹4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the ₹1,500-crore issue by Vijaya Diagnostic Centre and Mumbai-based bulk drugs maker Supriya Lifesciences ( ₹1,200 crore). Investment bankers estimate these five companies to together raise over ₹8,300 crore through the public offerings this month, reported news agency PTI.

Leave a Reply

Your email address will not be published. Required fields are marked *